Primmune Therapeutics Announces Additional Close of Series B Financing
SAN DIEGO, Jan. 26, 2026 (GLOBE NEWSWIRE) — Today, Primmune Therapeutics, a biotech company harnessing the power of the innate immune system, announced an additional close of its Series B financing round for a total […]
